Merck KGaA says FY profit to fall to lower half of target range
By Ludwig Burger FRANKFURT (Reuters) -Germany's diversified group Merck KGaA flagged that full-year operating earnings would likely be in the
1970-01-01 08:00
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
TOKYO (Reuters) -Japan's Daiichi Sankyo announced on Friday a $5.5 billion agreement with Merck to jointly develop its three precision
1970-01-01 08:00
Germany's Merck flags steeper drop in earnings
By Ludwig Burger FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday warned of a steeper earnings decline on a slump in
1970-01-01 08:00
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna said on Wednesday it has begun enrolling patients in a late-stage study evaluating its personalised mRNA-based skin
1970-01-01 08:00
White House says it will win Merck lawsuit, defends Medicare drug negotiations
WASHINGTON The Biden administration is confident it will succeed in the courts against Merck & Co's lawsuit filed
1970-01-01 08:00
CEO of Germany's Merck: decoupling from China would be at huge economic cost
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) -The CEO of German technology group Merck KGaA said that unravelling trade
1970-01-01 08:00
Merck sues US government to halt Medicare drug price negotiation
By Michael Erman NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking an injunction of the
1970-01-01 08:00
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
By Julie Steenhuysen CHICAGO Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the
1970-01-01 08:00
Germany's Merck flags decline in operating profit of up to 10% in 2023
By Ludwig Burger FRANKFURT Germany's Merck KGaA on Thursday warned that adjusted operating earnings could decline by as
1970-01-01 08:00